Luis
Montuenga Badía
Catedrático de Universidad
Institute Catalá Oncología
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Institute Catalá Oncología (9)
2021
-
Multiplex RNA-based detection of clinically relevant MET alterations in advanced non-small cell lung cancer
Molecular Oncology, Vol. 15, Núm. 2, pp. 350-363
2020
-
Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors
Annals of Oncology, Vol. 31, Núm. 2, pp. 274-282
2018
-
Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis
The Lancet Respiratory Medicine, Vol. 6, Núm. 10, pp. 771-781
2017
-
Strategies to design clinical studies to identify predictive biomarkers in cancer research
Cancer Treatment Reviews, Vol. 53, pp. 79-97
2016
-
A novel epigenetic signature for early diagnosis in lung cancer
Clinical Cancer Research, Vol. 22, Núm. 13, pp. 3361-3371
2015
2013
-
A prognostic DNA methylation signature for stage I non-small-cell lung cancer
Journal of Clinical Oncology, Vol. 31, Núm. 32, pp. 4140-4147
2010
-
Complement factor H is elevated in bronchoalveolar lavage fluid and sputum from patients with lung cancer
Cancer Epidemiology Biomarkers and Prevention, Vol. 19, Núm. 10, pp. 2665-2672
2008
-
A microRNA DNA methylation signature for human cancer metastasis
Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Núm. 36, pp. 13556-13561